A Preview Of Adamis Pharmaceuticals's Earnings

A Preview Of Adamis Pharmaceuticals's Earnings

Adamis Pharmaceuticals ADMP is set to give its latest quarterly earnings report on Monday, 2022-11-14. Here's what investors need to know before the announcement.

Analysts estimate that Adamis Pharmaceuticals will report an earnings per share (EPS) of $-0.03.

Adamis Pharmaceuticals bulls will hope to hear the company to announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Historical Earnings Performance

Last quarter the company missed EPS by $0.03, which was followed by a 6.23% drop in the share price the next day.

Here's a look at Adamis Pharmaceuticals's past performance and the resulting price change:

 

Quarter Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -0.03 -0.03 -0.04     -0.06
EPS Actual -0.06 -0.07 -0.05 -0.06 -0.06 -0.12
Price Change % -6.23% -8.03% -0.33% -8.35% -8.35% -8.35%

Stock Performance

Shares of Adamis Pharmaceuticals were trading at $0.1494 as of November 10. Over the last 52-week period, shares are down 84.49%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release.

To track all earnings releases for Adamis Pharmaceuticals visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BZI-EPEarnings